Obstructive Sleep Apnea

>

Latest News

FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity | Image Credit: US Food and Drug Administration
FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity

December 20th 2024

Tirzepatide's approval marks the first and only prescription medicine available for adults with moderate-to-severe obstructive sleep apnea and obesity.

George Shaw, MD | Credit: Allegheny Health Network
AHN implants innovative device to manage central sleep apnea in heart failure patients

August 27th 2024

Nocturnal Hypoxia Linked to Wet Age-Related Macular Degeneration Risk | Image Credit: Centre for Eye Research Australia
Nocturnal Hypoxia Linked to Wet Age-Related Macular Degeneration Risk

August 23rd 2024

Cardiovascular Disease Rates is Greater in Younger Than Older Adults with OsA
Cardiovascular Disease Rate is Greater in Younger Than Older Adults with OSA

July 18th 2024

Pharyngeal Opening Pressure More Common in Black Patients with OSA
Pharyngeal Opening Pressure More Common in Black Patients with OSA

June 2nd 2024

© 2024 MJH Life Sciences

All rights reserved.